MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by RYAN, D. E.
Right arrow Articles by LEVIN, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by RYAN, D. E.
Right arrow Articles by LEVIN, W.

Molecular Pharmacology, Vol 13, 521-532, Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics

Properties of Purified Liver Microsomal Cytochrome P450 from Rats Treated with the Polychlorinated Biphenyl Mixture Aroclor 1254

DENE E. RYAN 1, PAUL E. THOMAS 1, and WAYNE LEVIN 1

1 Department of Biochemistry and Drug Metabolism, Hoffmann-La Roche, Inc., Nutley, New Jersey 07110

Hepatic microsomal cytochrome P450 has been purified from rats treated with Aroclor 1254 to a specific content of greater than 19.0 nmoles/mg of protein and compared with purified cytochromes P450 from phenobarbital- and 3-methylcholanthrene-treated rats. Cytochrome P450 from Aroclor 1254-treated rats cannot be distinguished from a mixture of hemeproteins from phenobarbital- and 3-methylcholanthrene-treated rats by its spectral and catalytic properties or its electrophoretic mobility on sodium dodecyl sulfate-polyacrylamide gels. The cross-reactivity of cytochrome P450 from Aroclon 1254-treated rats with antibodies prepared against the hemeproteins from phenobarbital- or 3-methylcholanthrene-treated rats has also been examined. On Ouchterlony double-diffusion plates the cross-reaction of the Arocbor 1254-inducible cytochrome P450 with either antibody is indistinguishable from the reaction of a mixture of hemeproteins from phenobarbital- and 3-methylcholanthrene-treated rats. When the antibody to cytochrome P450 from 3-methylcholanthrene-treated rats is used to inhibit metabolism, no differences are observed between cytochrome P450 from Aroclor 1254-treated rats and a mixture of hemeproteins from phenobarbital- and 3-methylcholanthrene-treated rats. However, the effects of the antibody to cytochrome P450 from phenobarbital-treated rats on the metabolism of 7-ethoxycoumarin and benzo[a]pyrene suggest that the hemeprotein preparation from Aroclor 1254-treated rats may differ in certain antigenic properties from a mixture of cytochromes P450 from phenobarbital-and 3-methylcholanthrene-treated rats.

Note:
ACKNOWLEDGMENTS We thank Drs. A. H. Conney and A. Y. H. Lu for their suggestions during the course of this work, and Ms. Susan B. West for the preparation of the NADPH-cytochrome c reductase. We also thank Ms. Candace Caso for her help in preparation of the manuscript.

Submitted on November 15, 1976
Accepted on January 19, 1977







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics